Cargando…
Glycyrrhizic acid glycosides reduces extensive tripterygium glycosides-induced lipid deposition in hepatocytes
AIM: Tripterygium glycosides (TG) extracted from the plant Tripterygium wilfordii Hook F has been used to treat chronic kidney diseases for many years. However, hepatotoxicity limits its clinical application. Glycyrrhizic acid glycosides (GA) can reduce TG hepatotoxicity, however, further investigat...
Autores principales: | Yang, Yifei, Fu, Xiaotong, Xia, Bing, Zhou, Liu, Zhang, Haijing, Li, Chun, Ye, Xiao, Liu, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362073/ https://www.ncbi.nlm.nih.gov/pubmed/37483744 http://dx.doi.org/10.1016/j.heliyon.2023.e17891 |
Ejemplares similares
-
Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models
por: Zheng, Bidan, et al.
Publicado: (2023) -
Glycyrrhizic Acid Mitigates Tripterygium-Glycoside-Tablet-Induced Acute Liver Injury via PKM2 Regulated Oxidative Stress
por: Wang, Qixin, et al.
Publicado: (2022) -
Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021) -
Effects of tripterygium glycosides on restenosis following endovascular treatment
por: HAN, BING, et al.
Publicado: (2016) -
Wells Syndrome Successfully Treated with Tripterygium Glycosides
por: Lu, Jiejie, et al.
Publicado: (2021)